FDA Investigator Meyer J Slobotsky

Meyer J Slobotsky has conducted inspections on 20 sites in 7 countries as of 16 Sep 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
20
Last Inspection Date:
16 Sep 2019
Investigator Role:
FDA Investigator
Redica ID:
100009010
Countries of Inspections:
Germany, Canada, United States of America, United Kingdom of Great Britain and Northern Ireland, Italy, Finland, India
FDA Investigators that have inspected at least one site in common with Meyer J Slobotsky:
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Amir Alavi, Amy L Singer, Amy M Codella, Amy M Cramer, Annemarie B Randow, Annemarie Bodnar, Atul J Agrawal, Azza Talaat, Barbara D Wright, Bruce H Mccullough, Byungja E Marciante, Carl A Huffman, III, Carla A Norris, Caryn M Mcnab, Cassandra L Abellard, Charisse K Green, Clotia Cabbey Mensah, Daniel J Grabicki, David A Oluwo, David J Gomes, David J Hafner, David K Lau, Dawn L Wydner, Denise M Visco, Investigator, Don H Bark, PhD, Donald L Lech, Donna Mwilliams Hill, PhD, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Edmund F Mrak, Jr, Edward D Mcdonald, Emest F Bizjak, Eric Rothschild, Erin D Mccaffery, Felix Maldonado, Frederick F Razzaghi, Gale E Ryan, Gerald B Seaborn, Jr, Ginger M Sykes, Grace E Mcnally, Guerlain Ulysse, Gwyn G Dickinson, Helen B Ricalde, James I Giefer, James L Dunnie, Jr, James R Birkenstamm, Janet A Rajan, Jean M Kelahan, Jenny Sung, Jessica L Pressley, Jessica S Estriplet, Joan A Loreng, Joel D Hustedt, Joey V Quitania, Jogy George, Johnna L Bleem, Jonathan S Helfgott, Jose Acruz Gonzalez, Jose M Cayuela, Josh Renzo N Ramilo, Joshua P Wireman, Joy Rkozlowski Klena, Julie D Bringger, Junho Pak, Justin A Boyd, Justine Tomasso, Karen E D'orazio, Katherine D Adams, Kelli F Dobilas, Kenneth H Williams, Kenneth M Gordon, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kinh Q Mac, Ko U Min, Kristen D Evans, Kristy A Zielny, Lauren L Vajo, Linda F Murphy, Linda K Cline, Loretta Nemchik, Luella J Rossi, Lydia I Rosas Marty, M Edith Snyder, Marcelo O Mangalindan, Jr, Marcus F Yambot, Marea K Harmon, Margaret M Sands, Maria Estrella, Marie A Fadden, Marie F Morin, Matthew A Spataro, Matthew B Casale, Mayar M Mussa, Melba Trivera Clavell, Melissa A Freeman, Melissa T Roy, Michael A Charles, Michael P Sheehan, Michael R Goga, Michael R Klapal, Michael Serrano, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nancy A Saxenian Emmons, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nebil A Oumer, Nerizza B Dalena, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Parul M Patel, Patrick C Klotzbuecher, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Raymond T Oji, Regina T Brown, Richard L Friedman, Robert J Doyle, Roger F Zabinski, Rose Ljean Mary, Russell J Glapion, Samir C Gala, Sarah Adella Fave, Satheesh K Podaralla, Shirley H Isbill, Shirley S Wen, Simone E Pitts, Sinai I Davis, Stephen J Mottola, Stephen R Souza, Stephenie M Ortiz, Steven B Hertz, Steven D Kehoe, Suchan Kim, Susan M Jackson, Susan T Hadman, Susanna E Ford, Tamil Arasu, PhD, Tara G Bizjak, Tara R Gooen, Tawny L Colling, Thomas J Arista, Victoria Spivak, Xiaoping Guan, Yumi J Hiramine, Yvesna C Blaise

Meyer J Slobotsky's Documents

Publish Date Document Type Title
March, 2001 FDA 483 Glaxo Smithkline - Form 483, 2001-03-15
April, 2003 EIR Bimeda-MTC Animal Health - EIR, 2003-04-03
March, 2004 EIR OHM LABORATORIES INC. - EIR, 2004-03-01
January, 2014 FDA 483 St. Peter's University Hospital - CPHSR - Form 483, 2014-01-13
March, 2018 EIR Patheon UK Limited - EIR, 2018-03-13
December, 2003 EIR Takeda GmbH - EIR, 2003-12-10
May, 2003 FDA 483 Able Laboratories, Inc. - Form 483, 2003-05-20
June, 2003 FDA 483 JAK Diversified II, Inc. dba Multi-Pak Packaging - Form 483, 2003-06-05
November, 2018 EIR Tianish Laboratories Private Limited - EIR, 2018-11-02
June, 2012 FDA 483 Guardian Drug Company - Form 483, 2012-06-08
September, 2001 EIR Bayer Oy - EIR, 2001-09-26
June, 2003 FDA 483 Response JAK Diversified II, Inc. dba Multi-Pak Packaging - Form 483R, 2003-07-01
December, 2003 FDA 483 Response Takeda GmbH - Form 483R, 2004-12-14
April, 2004 FDA 483 Guardian Drug Company - Form 483, 2004-04-23
September, 2019 EIR Latina Pharma S.P.A. - EIR, 2019-09-27
January, 2014 EIR St. Peter's University Hospital - CPHSR - EIR, 2014-01-13
October, 2003 FDA 483 VILS Pharma Coating LLC - Form 483, 2003-10-22
September, 2007 EIR Sanofi-Aventis U.S. LLC - EIR, 2007-09-25
December, 2003 FDA 483 Takeda GmbH - Form 483, 2003-12-10
August, 2004 EIR Able Laboratories Inc. - EIR, 2004-08-04
October, 2003 EIR VILS Pharma Coating LLC - EIR, 2003-10-22
December, 2001 FDA 483 Response Merck, Inc. - Form 483R, 2002-01-25
September, 2007 FDA 483 Sanofi-Aventis U.S. LLC - Form 483, 2007-09-26
May, 2005 EIR J & J Pharmaceutical Research & Develop - EIR, 2005-05-06
May, 2003 EIR Able Laboratories, Inc. - EIR, 2003-05-20
December, 2001 FDA 483 Merck, Inc. - Form 483, 2001-12-19
December, 2001 EIR Merck, Inc. - EIR, 2001-12-19
October, 2008 EIR Piramal Healthcare (Canada) Limited - EIR, 2016-06-15
September, 2007 FDA 483 Response Sanofi-Aventis U.S. LLC - Form 483R, 2007-10-02
September, 2001 FDA 483 Response Bayer Oy - Form 483R, 2001-10-31
April, 2003 FDA 483 Bimeda-MTC Animal Health - Form 483, 2003-04-03
June, 2003 EIR JAK Diversified II, Inc. dba Multi-Pak Packaging - EIR, 2003-06-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more